Newsroom
February 7, 2025
Liang Ma, PhD, assistant professor at the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and the Department of Pharmacology, and Agustin Ruiz, MD, professor and director of the Biggs Institute’s Biological Core laboratory, were both quoted in this article. Read More
January 29, 2025
Advancement in the detection and treatment of Alzheimer’s and other neurodegenerative diseases means more people can preserve brain health for longer. But a crisis looms as an onslaught of people at risk for neurodegenerative diseases in the next 40 years is met with a shortage of health care providers. According to the U.S. […]
January 22, 2025
Late-onset Alzheimer’s disease is a debilitating, progressive neurodegenerative disease that affects about 7 million Americans, a figure that is expected to nearly double by 2050, according to the Alzheimer’s Association. While there is no cure for the disease, early detection and treatment can preserve brain function for longer. A study by researchers at The University […]
January 22, 2025
In the coming years, Africa is expected to sustain the greatest increase in Alzheimer’s and related dementia cases. Advancing the ability of African scientists to conduct research in these fields is critical for progress in understanding and treating these conditions. A transformative training program crafted through a collaboration between the Glenn Biggs Institute for Alzheimer’s […]
November 21, 2024
Hispanics have a higher dementia risk from vascular injury A new neuroimaging marker of cerebral small vessel disease is related to general cognition and may serve to identify persons at risk of dementia in future clinical trials, a landmark study has found. The study led by researchers at The University of Texas Health Science Center at […]
September 17, 2024
In landmark research, scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have reported the largest-ever genome-wide association study of dementia from all causes, revealing an overlap of genetic risks including neurodegeneration, vascular factors and cerebral small-vessel disease. Genome-wide association studies help scientists identify genes associated with […]
